Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke

BACKGROUND: IV tissue plasminogen activator (tPA) is the treatment of choice for ischemic strokes that present within the treatment window. In the majority of patients, this offers an effective and often life-prolonging treatment in the acute setting. In a rare set of patients treated with IV tPA, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaucer, Benjamin, Whelan, Dustin, Veys, Christopher, Upadhyaya, Manas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925031/
https://www.ncbi.nlm.nih.gov/pubmed/29850270
http://dx.doi.org/10.1155/2018/3257215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925031/
https://www.ncbi.nlm.nih.gov/pubmed/29850270
http://dx.doi.org/10.1155/2018/3257215

Ejemplares similares